Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement

Affiliations

• ¹ Department of Neurology, University of California San Francisco, San Francisco, CA, USA winston.chiong@ucsf.edu.
• ² Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
• ³ School of Law, University of Virginia, Charlottesville, VA, USA.
• ⁴ Department of Neurology, University of Florida, Gainesville, FL, USA.
• ⁵ Department of Neurology, Paul L. Foster School of Medicine Texas Tech University Health Sciences Center, El Paso, TX, USA.
• ⁶ Departments of Neurology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
• ⁷ Department of Neurology, Houston Methodist Hospital, Houston, TX, USA.
• ⁸ Neuroethics Canada and Division of Neurology, University of British Columbia, Vancouver, BC, Canada.
• ⁹ Departments of Anesthesia & Critical Care, Pediatrics and Neurology, Children's Hospital of Pennsylvania, Philadelphia, PA, USA.
• ¹⁰ Inova Neuroscience and Spine Institute, Falls Church, VA, USA.
• ¹¹ Department of Neurology, Duke University, Durham, NC, USA.
• ¹² Departments of Neurology & Neurotherapeutics and Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
• ¹³ Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
• ¹⁴ Departments of Neurology and Neurosurgery, University of Washington, Seattle, WA, USA.